The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.

@article{Lee2011TheIO,
  title={The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer.},
  author={Maria Lee and Sang Wun Kim and Eun Ji Nam and Ga Won Yim and Sunghoon Kim and Young Tae Kim},
  journal={Gynecologic oncology},
  year={2011},
  volume={122 2},
  pages={238-41}
}
OBJECTIVE To evaluate the impact of both pretreatment thrombocytosis, and platelet count reduction post-adjuvant chemotherapy, on survival in patients with advanced epithelial ovarian cancer. METHODS Records of 179 women who underwent cytoreductive surgery for FIGO stage III or IV epithelial ovarian cancer and received six cycles of platinum/paclitaxel-based chemotherapy between July 1998 and March 2009 were retrospectively reviewed. Platelet ratio was defined as the preoperative platelet… CONTINUE READING